# A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers

> **NCT01002963** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 56 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04418948
- **DRUG:** PF-04418948
- **DRUG:** PF-04418948
- **DRUG:** PF-04418948
- **DRUG:** PF-04418948
- **DRUG:** PF-04418948
- **DRUG:** PF-04418948

## Key facts

- **NCT ID:** NCT01002963
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002963, "A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01002963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*